| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Pharmaceutical (& Medicine) • Diagnostics |
| Stages | Pre-seed, Seed |
| Investing | Israel |
| Investment Range | $500,000 - $2,500,000 |
We are a consortium of family offices, operators, and senior executives dedicated to investing in and nurturing early-stage Israeli healthcare, life sciences, synthetic biology, and biomanufacturing startups. Leveraging a robust global network and deep domain expertise, we bridge the critical gaps from pre-seed to Series A, providing the necessary tools and support to position emerging ventures for future success.
We are a consortium of family offices, operators, and senior executives dedicated to investing in and nurturing early-stage Israeli healthcare, life sciences, synthetic biology, and biomanufacturing startups. Leveraging a robust global network and deep domain expertise, we bridge the critical gaps from pre-seed to Series A, providing the necessary tools and support to position emerging ventures for future success.
What we look for: We invest in Healthcare, Digital Health, Life Sciences, Synthetic Biology, and Biomanufacturing early stage startups from Pre-Seed to Series A, focused on stages ranging from Pre-Product, through Pre-Revenue, to Early Revenues.
How we help: We provide all the the necessary tools and support to position our portfolio companies for future success. Our multi-disciplinary team of experienced operators and serial entrepreneurs, led by a seasoned and savvy healthcare and biotech investor, collaborates closely with a dedicated community of C-level executives and thought leaders. This unique structure enables us to outline significant problems, identify innovative solutions, and accelerate market fit and talent acquisition.
